--- title: Recent Posts | News (5) description: News | (5) --- - [Our Customers and Partners](http://www.congenica.com/our-customers) - [Our Product Portfolio](http://www.congenica.com/congenica-products) - **Inherited Diseases** - [Rare Disease](http://www.congenica.com/congenica-rare-disease) - [Inherited Cancer](http://www.congenica.com/congenica-inherited-cancer) - [Prenatal Health](http://www.congenica.com/congenica-prenatal) - [Carrier Screening](http://www.congenica.com/congenica-carrier-screening) - [Neurodevelopmental Disorders](http://www.congenica.com/congenica-neuro) - **Somatic Oncology** - [Solid Tumours](http://www.congenica.com/congenica-oncology) - **Pathogen** - [Pathogen Surveillance](http://www.congenica.com/congenica-pathogen-surveillance) - [Our Services](http://www.congenica.com/congenica-services) - [Clinical Interpretation Services](http://www.congenica.com/congenica-clinical-interpretation-services) - [Professional Services](http://www.congenica.com/professional-services) - [Customer Support](http://www.congenica.com/customer-support) - [Pharma Services](http://www.congenica.com/pharma-services) - Resources - [News](https://blog.congenica.com/) - [About us](http://www.congenica.com) - [Leadership Team](http://www.congenica.com/leadership) - [Quality](http://www.congenica.com/quality) - [Investors](http://www.congenica.com/investors) - [People and Vacancies](http://www.congenica.com/people) - [Contact us](http://www.congenica.com/contact) Login ##### Please select your location and reference genome: [America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/) # Latest News and Blogs ![Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification](https://blog.congenica.com/hs-fs/hubfs/Data%204_Light_Banner.jpg?width=320&height=192&name=Data%204_Light_Banner.jpg) 12/9/2020 #### [Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification](https://blog.congenica.com/overcoming-challenges-to-accelerate-variant-classification) As more cases undergo genomic testing and the global supply of classified genomic data increases, reducing repetitive work is essential to scaling access to genomic analysis. ![Inclusion in AJHG “Year in Review” 2020](https://blog.congenica.com/hs-fs/hubfs/AJHG%20Year%20in%20Review.jpg?width=320&height=192&name=AJHG%20Year%20in%20Review.jpg) 12/7/2020 #### [Inclusion in AJHG “Year in Review” 2020](https://blog.congenica.com/inclusion-in-ajhg-year-in-review-2020) The American Journal of Human Genetics has published its Genomic Medicine Year in Review for 2020, which includes a study featuring Congenica. ![Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer](https://blog.congenica.com/hs-fs/hubfs/Muthu-transparent-bg-v2.png?width=320&height=192&name=Muthu-transparent-bg-v2.png) 12/1/2020 #### [Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer](https://blog.congenica.com/congenica-appoints-dr.-muthu-meyyappan-as-chief-commercial-officer) Dr. Muthu Meyyappan appointed Chief Commercial Officer (CCO), of Congenica. Based in Boston, MA, Muthu will lead Congenica’s global market expansion. ![Congenica Appoints Dr. Sam Roberts as Non-Executive Director](https://blog.congenica.com/hs-fs/hubfs/Sam%20Roberts%20picture.jpg?width=320&height=192&name=Sam%20Roberts%20picture.jpg) 11/20/2020 #### [Congenica Appoints Dr. Sam Roberts as Non-Executive Director](https://blog.congenica.com/congenica-appoints-dr-sam-roberts-as-non-executive-director) Congenica appoints Dr. Sam Roberts as Non-Executive Director to the Board. Sam is the Managing Director of Health & Care at Legal & General. ![Inherited Disorders: Bioinformatic Analysis that Surpasses All Others](https://blog.congenica.com/hs-fs/hubfs/social-suggested-images/genomics.congenica.comhubfsClinicians-1-13.png?width=320&height=192&name=genomics.congenica.comhubfsClinicians-1-13.png) 11/17/2020 #### [Inherited Disorders: Bioinformatic Analysis that Surpasses All Others](https://blog.congenica.com/inherited-disorders-new-study-highlights-bioinformatic-analysis) A recent study has shown that the Congenica platform demonstrated a superior role identifying the genetic causes of platelet-related bleeding disorders ![Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform](https://blog.congenica.com/hs-fs/hubfs/social-suggested-images/genomics.congenica.comhubfsBaby%20on%20shoulder-7.jpg?width=320&height=192&name=genomics.congenica.comhubfsBaby%20on%20shoulder-7.jpg) 11/9/2020 #### [Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform](https://blog.congenica.com/congenica-completes-50m-series-c-funding-round-to-advance-clinical-genomic-analysis-software-and-data-platform) New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations ![Genome UK: the future of healthcare](https://blog.congenica.com/hs-fs/hubfs/social-suggested-images/genomics.congenica.comhubfssocial-suggested-imagesgenomics.congenica.comhubfsGenetics_People-5.jpg?width=320&height=192&name=genomics.congenica.comhubfssocial-suggested-imagesgenomics.congenica.comhubfsGenetics_People-5.jpg) 10/5/2020 #### [Genome UK: the future of healthcare](https://blog.congenica.com/genome-uk-the-future-of-healthcare) Congenica's response to the UK Government's national genomic healthcare strategy, setting out its vision to extend the UK’s leadership in genomics ![Congenica Launches New Host Genetics Module to Advance COVID-19 Research](https://blog.congenica.com/hs-fs/hubfs/covid_2_light.jpg?width=320&height=192&name=covid_2_light.jpg) 9/22/2020 #### [Congenica Launches New Host Genetics Module to Advance COVID-19 Research](https://blog.congenica.com/congenica-launches-new-host-genetics-module-to-advance-covid-19-research) Congenica's new module accelerates research into the relationship between an individual’s genomic variation & COVID-19 susceptibility & clinical outcomes. ![Congenica Express Further Accelerates Identification of Genetic Diseases](https://blog.congenica.com/hs-fs/hubfs/data%20image%202.jpg?width=320&height=192&name=data%20image%202.jpg) 7/15/2020 #### [Congenica Express Further Accelerates Identification of Genetic Diseases](https://blog.congenica.com/congenica-automation-further-accelerates-identification-of-genetic-diseases) Congenica launches an update that will provide automated classification, evidence and reporting of recurrent ‘known’ variants, significantly saving time. ![Congenica Prenatal to enable faster research of fetal anomalies in critical prenatal settings](https://blog.congenica.com/hs-fs/hubfs/Ultrasound_1.jpg?width=320&height=192&name=Ultrasound_1.jpg) 6/4/2020 #### [Congenica Prenatal to enable faster research of fetal anomalies in critical prenatal settings](https://blog.congenica.com/congenica-prenatal-to-enable-faster-research-of-fetal-anomalies-in-critical-prenatal-settings) Congenica launches Congenica Prenatal, a new application that facilitate faster, more accurate and comprehensive molecular research into fetal anomalies. ![Genomics England Announces New Project to Help in the Fight Against COVID-19](https://blog.congenica.com/hs-fs/hubfs/Genomics%20England%20Genomicc_2-2.jpg?width=320&height=192&name=Genomics%20England%20Genomicc_2-2.jpg) 5/13/2020 #### [Genomics England Announces New Project to Help in the Fight Against COVID-19](https://blog.congenica.com/genomics-england-announces-new-project-to-help-in-the-fight-against-covid-19) Genomics England has announced a major new sequencing project to uncover how a person’s genetic make-up influences their susceptibility to COVID-19. ![Congenica v2.4: Submit and interpret data faster with greater flexibility](https://blog.congenica.com/hs-fs/hubfs/Clinician_4-2.jpg?width=320&height=192&name=Clinician_4-2.jpg) 4/29/2020 #### [Congenica v2.4: Submit and interpret data faster with greater flexibility](https://blog.congenica.com/congenica-v2.4-helping-you-submit-and-interpret-data-faster-with-greater-flexibility) With case loads increasing every day, clinical teams are experiencing increasing pressure to make their variant interpretation more efficient. ##### Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory. - [Privacy Policy](http://www.congenica.com/privacy-policy) - [Cookie Policy](http://www.congenica.com/cookie-policy) Log in to Congenica ##### Please select your location and reference genome: [America - GRCh37](https://us-37.congenica.com/) [America - GRCh38](https://us-38.congenica.com/) [Europe, Middle East, Africa - GRCh37](https://eu-37.congenica.com/) [Europe, Middle East, Africa - GRCh38](https://eu-38.congenica.com/) ![CE](https://blog.congenica.com/hs-fs/hubfs/CE.png?width=80&height=80&name=CE.png) ![ISO-27001](https://blog.congenica.com/hs-fs/hubfs/ISO-27001.jpg?width=80&height=80&name=ISO-27001.jpg) ![TR-Testmark\_9000030872\_EN\_2024\_CMYK](https://blog.congenica.com/hs-fs/hubfs/2023%20website%20images/TR-Testmark_9000030872_EN_2024_CMYK.png?width=80&height=80&name=TR-Testmark_9000030872_EN_2024_CMYK.png) ![HIPAA Compliant](https://blog.congenica.com/hs-fs/hubfs/HIPAA%20Compliant.png?width=80&height=80&name=HIPAA%20Compliant.png) Copyright © 2026 Congenica Ltd. Company number: 8273616 Registered in England and Wales.